New pill takes aim at Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage study tests an experimental oral drug called GIM-531 in people with advanced solid tumors (including stage IV melanoma) that have stopped responding to standard treatments. The drug works by targeting certain immune cells to help the body fight cancer. Researcher…
Phase: PHASE1, PHASE2 • Sponsor: Georgiamune Inc • Aim: Disease control
Last updated May 13, 2026 15:58 UTC